Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,399 | 89,772 | 77,202 | 33,675 | 27,094 |
| Marketable Securities | 2,446 | 25,264 | 54,735 | 93,452 | 120,311 |
| Receivables | 241 | 2,452 | 3,177 | 2,834 | 2,740 |
| Other current assets | 15 | 0 | 0 | 139 | 43 |
| TOTAL | $132,983 | $123,855 | $142,724 | $136,369 | $154,585 |
| Non-Current Assets | |||||
| PPE Net | 5,752 | 6,063 | 6,363 | 6,730 | 7,070 |
| Other Non-Current Assets | 9,970 | 10,073 | 10,176 | 10,274 | 10,344 |
| TOTAL | $15,722 | $16,136 | $16,539 | $17,004 | $17,414 |
| Total Assets | $148,705 | $139,991 | $159,263 | $153,373 | $171,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 508 | 230 | 265 | 352 |
| Accrued Expenses | 7,631 | 6,811 | 9,017 | 6,224 | 7,022 |
| TOTAL | $8,670 | $8,303 | $10,178 | $7,369 | $9,618 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,413 |
| Other Non-Current Liabilities | 14,569 | 14,899 | 15,173 | 15,310 | 15,546 |
| TOTAL | $17,319 | $17,649 | $17,923 | $18,060 | $18,296 |
| Total Liabilities | $25,989 | $25,952 | $28,101 | $25,429 | $27,914 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,174 | 32,174 | 32,174 | 30,649 | 29,678 |
| Common Shares | 31 | 31 | 31 | 29 | 29 |
| Retained earnings | -286,691 | -292,116 | -269,447 | -247,057 | -228,149 |
| Other shareholders' equity | -76 | -74 | -58 | 35 | 176 |
| TOTAL | $122,716 | $114,039 | $131,162 | $127,944 | $144,085 |
| Total Liabilities And Equity | $148,705 | $139,991 | $159,263 | $153,373 | $171,999 |